List of Chapters/Sections(Table Of Content)
1 Evolocumab Market Overview
1.1 Product Overview and Scope of Evolocumab
1.2 Evolocumab Segment by Type
1.2.1 Global Evolocumab Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Patent
1.2.3 Generic
1.3 Evolocumab Segment by Application
1.3.1 Global Evolocumab Sales Comparison by Application: (2022-2028)
1.3.2 Chemical
1.3.3 Pharmaceutical
1.4 Global Evolocumab Market Size Estimates and Forecasts
1.4.1 Global Evolocumab Revenue 2017-2028
1.4.2 Global Evolocumab Sales 2017-2028
1.4.3 Evolocumab Market Size by Region: 2017 Versus 2021 Versus 2028
2 Evolocumab Market Competition by Manufacturers
2.1 Global Evolocumab Sales Market Share by Manufacturers (2017-2022)
2.2 Global Evolocumab Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Evolocumab Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Evolocumab Manufacturing Sites, Area Served, Product Type
2.5 Evolocumab Market Competitive Situation and Trends
2.5.1 Evolocumab Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Evolocumab Players Market Share by Revenue
2.5.3 Global Evolocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Evolocumab Retrospective Market Scenario by Region
3.1 Global Evolocumab Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Evolocumab Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Evolocumab Market Facts & Figures by Country
3.3.1 North America Evolocumab Sales by Country
3.3.2 North America Evolocumab Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Evolocumab Market Facts & Figures by Country
3.4.1 Europe Evolocumab Sales by Country
3.4.2 Europe Evolocumab Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Evolocumab Market Facts & Figures by Region
3.5.1 Asia Pacific Evolocumab Sales by Region
3.5.2 Asia Pacific Evolocumab Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Evolocumab Market Facts & Figures by Country
3.6.1 Latin America Evolocumab Sales by Country
3.6.2 Latin America Evolocumab Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Evolocumab Market Facts & Figures by Country
3.7.1 Middle East and Africa Evolocumab Sales by Country
3.7.2 Middle East and Africa Evolocumab Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Evolocumab Historic Market Analysis by Type
4.1 Global Evolocumab Sales Market Share by Type (2017-2022)
4.2 Global Evolocumab Revenue Market Share by Type (2017-2022)
4.3 Global Evolocumab Price by Type (2017-2022)
5 Global Evolocumab Historic Market Analysis by Application
5.1 Global Evolocumab Sales Market Share by Application (2017-2022)
5.2 Global Evolocumab Revenue Market Share by Application (2017-2022)
5.3 Global Evolocumab Price by Application (2017-2022)
6 Key Companies Profiled
6.1 BOCSCI
6.1.1 BOCSCI Corporation Information
6.1.2 BOCSCI Description and Business Overview
6.1.3 BOCSCI Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.1.4 BOCSCI Evolocumab Product Portfolio
6.1.5 BOCSCI Recent Developments/Updates
6.2 Carbosynth
6.2.1 Carbosynth Corporation Information
6.2.2 Carbosynth Description and Business Overview
6.2.3 Carbosynth Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Carbosynth Evolocumab Product Portfolio
6.2.5 Carbosynth Recent Developments/Updates
6.3 TargetMol Chemicals
6.3.1 TargetMol Chemicals Corporation Information
6.3.2 TargetMol Chemicals Description and Business Overview
6.3.3 TargetMol Chemicals Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.3.4 TargetMol Chemicals Evolocumab Product Portfolio
6.3.5 TargetMol Chemicals Recent Developments/Updates
6.4 Chemren Bio-Engineering
6.4.1 Chemren Bio-Engineering Corporation Information
6.4.2 Chemren Bio-Engineering Description and Business Overview
6.4.3 Chemren Bio-Engineering Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Chemren Bio-Engineering Evolocumab Product Portfolio
6.4.5 Chemren Bio-Engineering Recent Developments/Updates
6.5 DC Chemicals
6.5.1 DC Chemicals Corporation Information
6.5.2 DC Chemicals Description and Business Overview
6.5.3 DC Chemicals Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.5.4 DC Chemicals Evolocumab Product Portfolio
6.5.5 DC Chemicals Recent Developments/Updates
6.6 Hefei Enli Medical Technology
6.6.1 Hefei Enli Medical Technology Corporation Information
6.6.2 Hefei Enli Medical Technology Description and Business Overview
6.6.3 Hefei Enli Medical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hefei Enli Medical Technology Evolocumab Product Portfolio
6.6.5 Hefei Enli Medical Technology Recent Developments/Updates
6.7 Hefei Hirisun Pharmatech
6.6.1 Hefei Hirisun Pharmatech Corporation Information
6.6.2 Hefei Hirisun Pharmatech Description and Business Overview
6.6.3 Hefei Hirisun Pharmatech Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hefei Hirisun Pharmatech Evolocumab Product Portfolio
6.7.5 Hefei Hirisun Pharmatech Recent Developments/Updates
6.8 Hubei Kele Fine Chemical
6.8.1 Hubei Kele Fine Chemical Corporation Information
6.8.2 Hubei Kele Fine Chemical Description and Business Overview
6.8.3 Hubei Kele Fine Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hubei Kele Fine Chemical Evolocumab Product Portfolio
6.8.5 Hubei Kele Fine Chemical Recent Developments/Updates
6.9 Hubei Xingcheng Biotechnology
6.9.1 Hubei Xingcheng Biotechnology Corporation Information
6.9.2 Hubei Xingcheng Biotechnology Description and Business Overview
6.9.3 Hubei Xingcheng Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hubei Xingcheng Biotechnology Evolocumab Product Portfolio
6.9.5 Hubei Xingcheng Biotechnology Recent Developments/Updates
6.10 Hubei Zhongshan Medical Technology
6.10.1 Hubei Zhongshan Medical Technology Corporation Information
6.10.2 Hubei Zhongshan Medical Technology Description and Business Overview
6.10.3 Hubei Zhongshan Medical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Hubei Zhongshan Medical Technology Evolocumab Product Portfolio
6.10.5 Hubei Zhongshan Medical Technology Recent Developments/Updates
6.11 Nantong Feiyu Biological Technology
6.11.1 Nantong Feiyu Biological Technology Corporation Information
6.11.2 Nantong Feiyu Biological Technology Evolocumab Description and Business Overview
6.11.3 Nantong Feiyu Biological Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Nantong Feiyu Biological Technology Evolocumab Product Portfolio
6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
6.12 Nantong Hi-Future Biotechnology
6.12.1 Nantong Hi-Future Biotechnology Corporation Information
6.12.2 Nantong Hi-Future Biotechnology Evolocumab Description and Business Overview
6.12.3 Nantong Hi-Future Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Nantong Hi-Future Biotechnology Evolocumab Product Portfolio
6.12.5 Nantong Hi-Future Biotechnology Recent Developments/Updates
6.13 Shanghai Biochempartner
6.13.1 Shanghai Biochempartner Corporation Information
6.13.2 Shanghai Biochempartner Evolocumab Description and Business Overview
6.13.3 Shanghai Biochempartner Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shanghai Biochempartner Evolocumab Product Portfolio
6.13.5 Shanghai Biochempartner Recent Developments/Updates
6.14 Shanghai Loulan Biotechnology
6.14.1 Shanghai Loulan Biotechnology Corporation Information
6.14.2 Shanghai Loulan Biotechnology Evolocumab Description and Business Overview
6.14.3 Shanghai Loulan Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Shanghai Loulan Biotechnology Evolocumab Product Portfolio
6.14.5 Shanghai Loulan Biotechnology Recent Developments/Updates
6.15 Shanghai Macklin Biochemical
6.15.1 Shanghai Macklin Biochemical Corporation Information
6.15.2 Shanghai Macklin Biochemical Evolocumab Description and Business Overview
6.15.3 Shanghai Macklin Biochemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shanghai Macklin Biochemical Evolocumab Product Portfolio
6.15.5 Shanghai Macklin Biochemical Recent Developments/Updates
6.16 Shanghai Minkai Biotechnology
6.16.1 Shanghai Minkai Biotechnology Corporation Information
6.16.2 Shanghai Minkai Biotechnology Evolocumab Description and Business Overview
6.16.3 Shanghai Minkai Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Shanghai Minkai Biotechnology Evolocumab Product Portfolio
6.16.5 Shanghai Minkai Biotechnology Recent Developments/Updates
6.17 Shanghai Ruihui Chemical Technology
6.17.1 Shanghai Ruihui Chemical Technology Corporation Information
6.17.2 Shanghai Ruihui Chemical Technology Evolocumab Description and Business Overview
6.17.3 Shanghai Ruihui Chemical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Shanghai Ruihui Chemical Technology Evolocumab Product Portfolio
6.17.5 Shanghai Ruihui Chemical Technology Recent Developments/Updates
6.18 Shanghai Yifei Biotechnology
6.18.1 Shanghai Yifei Biotechnology Corporation Information
6.18.2 Shanghai Yifei Biotechnology Evolocumab Description and Business Overview
6.18.3 Shanghai Yifei Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Shanghai Yifei Biotechnology Evolocumab Product Portfolio
6.18.5 Shanghai Yifei Biotechnology Recent Developments/Updates
6.19 Sichuan Weiqi Biotechnology
6.19.1 Sichuan Weiqi Biotechnology Corporation Information
6.19.2 Sichuan Weiqi Biotechnology Evolocumab Description and Business Overview
6.19.3 Sichuan Weiqi Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Sichuan Weiqi Biotechnology Evolocumab Product Portfolio
6.19.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
6.20 Taizhou KEDE Chemical
6.20.1 Taizhou KEDE Chemical Corporation Information
6.20.2 Taizhou KEDE Chemical Evolocumab Description and Business Overview
6.20.3 Taizhou KEDE Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Taizhou KEDE Chemical Evolocumab Product Portfolio
6.20.5 Taizhou KEDE Chemical Recent Developments/Updates
6.21 Taizhou Kerui Bio-Technology
6.21.1 Taizhou Kerui Bio-Technology Corporation Information
6.21.2 Taizhou Kerui Bio-Technology Evolocumab Description and Business Overview
6.21.3 Taizhou Kerui Bio-Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Taizhou Kerui Bio-Technology Evolocumab Product Portfolio
6.21.5 Taizhou Kerui Bio-Technology Recent Developments/Updates
6.22 WeiShi Reagent
6.22.1 WeiShi Reagent Corporation Information
6.22.2 WeiShi Reagent Evolocumab Description and Business Overview
6.22.3 WeiShi Reagent Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.22.4 WeiShi Reagent Evolocumab Product Portfolio
6.22.5 WeiShi Reagent Recent Developments/Updates
6.23 Wuhan Fortuna Chemical
6.23.1 Wuhan Fortuna Chemical Corporation Information
6.23.2 Wuhan Fortuna Chemical Evolocumab Description and Business Overview
6.23.3 Wuhan Fortuna Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Wuhan Fortuna Chemical Evolocumab Product Portfolio
6.23.5 Wuhan Fortuna Chemical Recent Developments/Updates
6.24 Wuhan Sunrise Technology Development
6.24.1 Wuhan Sunrise Technology Development Corporation Information
6.24.2 Wuhan Sunrise Technology Development Evolocumab Description and Business Overview
6.24.3 Wuhan Sunrise Technology Development Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Wuhan Sunrise Technology Development Evolocumab Product Portfolio
6.24.5 Wuhan Sunrise Technology Development Recent Developments/Updates
6.25 Wuhan Weisman Bioengineering
6.25.1 Wuhan Weisman Bioengineering Corporation Information
6.25.2 Wuhan Weisman Bioengineering Evolocumab Description and Business Overview
6.25.3 Wuhan Weisman Bioengineering Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Wuhan Weisman Bioengineering Evolocumab Product Portfolio
6.25.5 Wuhan Weisman Bioengineering Recent Developments/Updates
6.26 Wuhan Yingnuo Pharmaceutical Technology
6.26.1 Wuhan Yingnuo Pharmaceutical Technology Corporation Information
6.26.2 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Description and Business Overview
6.26.3 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product Portfolio
6.26.5 Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
7 Evolocumab Manufacturing Cost Analysis
7.1 Evolocumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Evolocumab
7.4 Evolocumab Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Evolocumab Distributors List
8.3 Evolocumab Customers
9 Evolocumab Market Dynamics
9.1 Evolocumab Industry Trends
9.2 Evolocumab Market Drivers
9.3 Evolocumab Market Challenges
9.4 Evolocumab Market Restraints
10 Global Market Forecast
10.1 Evolocumab Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Evolocumab by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Evolocumab by Type (2023-2028)
10.2 Evolocumab Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Evolocumab by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Evolocumab by Application (2023-2028)
10.3 Evolocumab Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Evolocumab by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Evolocumab by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
